Patents by Inventor Jack Scott

Jack Scott has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240157378
    Abstract: A water conserving showerhead saves over 70 % of the water used during a traditional shower, while providing the same comfort and cleaning effects. The showerhead may include a motion sensor, a personal computer (PC) board, a temperature sensor, and a ball valve. The showerhead is used by first turning on the showerhead via an application (app) on a mobile device and the PC board or similar means. When the showerhead is started, the ball valve opens and allows the cold water within the showerhead and pipes to exit. When the temperature sensor detects the desired water temperature, the ball valve is closed, and the shower is ready for the user. During the shower, the user may step out of the active shower area for numerous reasons. A motion sensor detects when the user steps outside of the active shower area, and the ball valve is closed, shutting off the water.
    Type: Application
    Filed: November 13, 2023
    Publication date: May 16, 2024
    Inventors: Steve Scott Burns, Jack Dale Browning
  • Publication number: 20240109030
    Abstract: A system and method recover process gas from a source volume at a source pressure to a destination volume at an equal or greater pressure. A regulation process receive the process gas from the source volume and steps down the pressure. Each regulation uses one or more stage each using a pressure control valve for pressure step down and a heat exchanger for reheating the process gas thereafter. A gas scrubber receives the process gas from the regulation stages and collecting liquid from the process gas. A compression process receives the process gas from the gas scrubber and steps up the intermediate pressure to a final pressure. The compression can use one or more compression stages, each having a compression cycle for pressure step up and a heat exchanger for cooling the process gas thereafter. A discharge vessel receives the process gas from the compression process and discharges the process gas at the final pressure to the destination volume.
    Type: Application
    Filed: December 8, 2023
    Publication date: April 4, 2024
    Inventors: Adam Scott Murray, Eric Heinle, Jack A. Smith, William Stratton
  • Patent number: 11923593
    Abstract: An antenna pedestal including: a body having an inner cavity defined by a wall and a top ledge; a Heating, ventilation, and air conditioning (HVAC) system to provide climate control for the inner cavity; and a door to access the inner cavity of the body, wherein the top ledge supports a mechanical steering.
    Type: Grant
    Filed: May 19, 2022
    Date of Patent: March 5, 2024
    Assignee: Hughes Network Systems, LLC
    Inventors: Michael Scott, Jack Lundstedt, Walter Kepley
  • Patent number: 11915619
    Abstract: A self-laminating rotating cable marker label is constructed of a transparent film having a first adhesive area, an adhesive-free smooth area, and a second adhesive area. A print-on area forms one side of the transparent film, the print-on area adapted to receive indicia identifying the cable about which the marker label is applied. A perforation extends across the transparent film providing a line of separation of the transparent film. When wrapped around a cable, the second adhesive area overlies the print-on area such that the cable identifying indicia is visible through the transparent second adhesive area. As the transparent film is wrapped around the cable, the first adhesive area adheres to the cable. The remainder of the transparent film is rotated, breaking the perforation, whereby the smooth area of the film in contact with the cable provides smooth rotation of the label around the cable.
    Type: Grant
    Filed: April 10, 2023
    Date of Patent: February 27, 2024
    Assignee: Panduit Corp.
    Inventors: Jack E. Caveney, David Scott Morrison, Michael Scott Adams
  • Publication number: 20190319313
    Abstract: A battery enclosure including a battery case for enclosing at least one cell in contact with an electrolyte; a positive post and a negative post connected to the at least one cell and protruding from the case; the case having a recess shaped to receive an electronic battery performance enhancement device (EBPED); and a cover that covers the recess and the EBPED when received in the recess such that the EBPED, including positive and negative leads of the EBPED when connected to the positive post and the negative post, are beneath the cover.
    Type: Application
    Filed: April 17, 2019
    Publication date: October 17, 2019
    Inventors: Jack A. SCOTT, Daniel C. BIGGS, Jr.
  • Patent number: 9688654
    Abstract: The present invention is directed to indazole compounds which are potent inhibitors of LRRK2 kinase and useful in the treatment or prevention of diseases in which the LRRK2 kinase is involved, such as Parkinson's Disease. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which LRRK2 kinase is involved.
    Type: Grant
    Filed: February 27, 2014
    Date of Patent: June 27, 2017
    Assignee: Merck Sharp & Dohme Corp.
    Inventors: Michael Miller, Kallol Basu, Duane DeMong, Jack Scott, Hong Liu, Xing Dai, Andrew Stamford, Marc Poirier, Paul Tempest
  • Patent number: 9493440
    Abstract: The present invention is directed to indazole compounds which are potent inhibitors of LRRK2 kinase and useful in the treatment or prevention of diseases in which the LRRK2 kinase is involved, such as Parkinson's Disease. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which LRRK-2 kinase is involved.
    Type: Grant
    Filed: February 27, 2014
    Date of Patent: November 15, 2016
    Assignee: Merck Sharp & Dohme Corp.
    Inventors: Michael Miller, Kallol Basu, Duane DeMong, Jack Scott, Wei Li, Andrew Stamford, Marc Poirer, Paul Tempest
  • Patent number: 9440952
    Abstract: The present invention is directed to indazole compounds which are potent inhibitors of LRRK2 kinase and useful in the treatment or prevention of diseases in which the LRRK2 kinase is involved, such as Parkinson's Disease. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which LRRK-2 kinase is involved.
    Type: Grant
    Filed: February 27, 2014
    Date of Patent: September 13, 2016
    Assignee: Merck Sharp & Dohme Corp.
    Inventors: Michael Miller, Kallol Basu, Duane DeMong, Jack Scott, Hong Liu, Xing Dai, Joel M. Harris, Bernard Neustadt, Andrew Stamford, Marc Poirier, John A. McCauley, Thomas Greshock, Heather Stevenson, John Sanders, Jonathan Kern
  • Patent number: 9416126
    Abstract: The present invention is directed to indazole compounds which are potent inhibitors of LRRK2 kinase and useful in the treatment or prevention of diseases in which the LRRK2 kinase is involved, such as Parkinson's Disease. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which LRRK-2 kinase is involved.
    Type: Grant
    Filed: February 27, 2014
    Date of Patent: August 16, 2016
    Assignee: Merck Sharp & Dohme Corp.
    Inventors: Michael Miller, Kallol Basu, Duane DeMong, Jack Scott, Wei Li, Joel Harris, Andrew Stamford, Marc Poirier, Paul Tempest
  • Publication number: 20160009682
    Abstract: The present invention is directed to indazole compounds which are potent inhibitors of LRRK2 kinase and useful in the treatment or prevention of diseases in which the LRRK2 kinase is involved, such as Parkinson's Disease. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which LRRK-2 kinase is involved.
    Type: Application
    Filed: February 27, 2014
    Publication date: January 14, 2016
    Inventors: Michael Miller, Kallol Basu, Duane DeMong, Jack Scott, Hong Liu, Xing Dai, Joel M. Harris, Bernard Neustadt, Andrew Stamford, Marc Poirier, John A. McCauley, Thomas Greshock, Heather Stevenson, John Sanders, Jonathan Kern
  • Publication number: 20160009689
    Abstract: The present invention is directed to indazole compounds which are potent inhibitors of LRRK2 kinase and useful in the treatment or prevention of diseases in which the LRRK2 kinase is involved, such as Parkinson's Disease. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which LRRK-2 kinase is involved.
    Type: Application
    Filed: February 27, 2014
    Publication date: January 14, 2016
    Applicant: Merck Sharp & Dohme Corp.
    Inventors: Michael Miller, Kallol Basu, Duane DeMong, Jack Scott, Wei Li, Andrew Stamford, Marc Poirer, Paul Tempest
  • Publication number: 20160009696
    Abstract: The present invention is directed to indazole compounds which are potent inhibitors of LRRK2 kinase and useful in the treatment or prevention of diseases in which the LRRK2 kinase is involved, such as Parkinson's Disease. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which LRRK-2 kinase is involved.
    Type: Application
    Filed: February 27, 2014
    Publication date: January 14, 2016
    Inventors: Michael Miller, Kallol Basu, Duane DeMong, Jack Scott, Wei Li, Joel Harris, Andrew Stamford, Marc Poirier, Paul Tempest
  • Publication number: 20160009681
    Abstract: The present invention is directed to indazole compounds which are potent inhibitors of LRRK2 kinase and useful in the treatment or prevention of diseases in which the LRRK2 kinase is involved, such as Parkinson's Disease. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which LRRK2 kinase is involved.
    Type: Application
    Filed: February 27, 2014
    Publication date: January 14, 2016
    Inventors: Michael Miller, Kallol Basu, Duane DeMong, Jack Scott, Hong Liu, Xing Dai, Andrew Stamford, Marc Poirier, Paul Tempest
  • Patent number: 8633710
    Abstract: Apparatus and methods are disclosed for obtaining an image of the impedance properties of an object by inferring a measure of straight-line path impedance along a plurality of paths from a plurality of current amplitude and phase measurements made between combinations of electrodes placed at selected points, and/or from measurements of the intensity of the electromagnetic signal emitted when an alternating current is made to resonate along the straight line path.
    Type: Grant
    Filed: August 31, 2011
    Date of Patent: January 21, 2014
    Inventor: Jack Scott Emery
  • Patent number: 8026731
    Abstract: Apparatus and methods are disclosed for obtaining an image of the impedance properties of an object by inferring a measure of straight-line path impedance along a plurality of paths from a plurality of current amplitude and phase measurements made between combinations of electrodes placed at selected points, and/or from measurements of the intensity of the electromagnetic signal emitted when an alternating current is made to resonate along the straight line path.
    Type: Grant
    Filed: April 20, 2007
    Date of Patent: September 27, 2011
    Inventor: Jack Scott Emery
  • Patent number: 7647615
    Abstract: An audio input interface (122) receives a digital audio signal and identifies an audio bitstream which is optionally decrypted by a decryption unit (123), and decoded by an audio decoding unit (124). An audio digital to analog converter (126) converts the decoded audio bitstream to an analog audio signal which is optionally decrypted by an audio analog decryption unit (127) and output by an audio output interface (128) to an analog wireline device (100). A video input interface (142) receives a digital video signal and identifies a video bitstream which is optionally decrypted by a video digital decryption unit (143), and decoded by a video decoding unit (144). A video digital to analog converter (146) converts the decoded video bitstream to an analog video signal that is optionally decrypted by a video analog decryption unit (147) and output by a video output interface (148) to the analog wireline device (100).
    Type: Grant
    Filed: May 4, 1998
    Date of Patent: January 12, 2010
    Assignee: Motorola, Inc.
    Inventors: Jurgen Reinold, David Knappenberger, Mathew Cucuzella, Jack Scott Geranen, Jeff Lee, Michael E. Williams
  • Publication number: 20080095740
    Abstract: The present invention provides a compound of the formula or a pharmaceutically acceptable salt or solvate thereof, wherein the various moieties are as defined in the specification. The present invention also provides pharmaceutical compositions containing the compound of this invention, and methods of treatment using the compound of this invention. The invention also relates to the use of a combination of a compound of this invention and one or more antiviral or other agents useful in the treatment of Human Immunodeficiency Virus (HIV). The invention further relates to the use of a compound of this invention, alone or in combination with another agent, in the treatment of solid organ transplant rejection, graft v. host disease, arthritis, rheumatoid arthritis, inflammatory bowel disease, atopic dermatitis, psoriasis, asthma, allergies or multiple sclerosis.
    Type: Application
    Filed: October 26, 2007
    Publication date: April 24, 2008
    Inventors: Michael Miller, Jack Scott
  • Publication number: 20080081160
    Abstract: A print receptive polyurethane coating is described. It is derived from a non-ionically stabilized polyurethane dispersion and an ink receptive particulate. Coatings and films for textiles and other articles and applications using such polyurethanes have been described.
    Type: Application
    Filed: September 28, 2007
    Publication date: April 3, 2008
    Applicant: LUBRIZOL ADVANCED MATERIALS, INC.
    Inventors: Gary Anderle, Jack Scott, Timothy Felmet
  • Publication number: 20070203183
    Abstract: A compound having the general structure of Formula (I): or a pharmaceutically acceptable salt, solvate, or ester thereof, are useful in treating diseases, disorders, or conditions such as metabolic syndrome (e.g., obesity, waist circumference, lipid profile, and insulin sensitivity), neuroinflammatory disorders, cognitive disorders, psychosis, addictive behavior, gastrointestinal disorders, and cardiovascular conditions.
    Type: Application
    Filed: January 11, 2007
    Publication date: August 30, 2007
    Inventors: Jack Scott, Jay Weinstein, Michael Miller, Andrew Stamford, Eric Gilbert, Yan Xia, William Greenlee, Sarah Li
  • Publication number: 20070197628
    Abstract: A compound having the general structure of Formula (I): or a pharmaceutically acceptable salt, solvate, or ester thereof, is useful in treating diseases, disorders, or conditions such as obesity, metabolic disorders, addiction, diseases of the central nervous system, cardiovascular disorders, respiratory disorders, and gastrointestinal disorders.
    Type: Application
    Filed: January 16, 2007
    Publication date: August 23, 2007
    Inventors: Samuel Chackalamannil, Mariappan Chelliah, Martin Clasby, Keith Eagen, Jack Scott, Yuguang Wang, Yan Xia, William Greenlee